Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome With Major Depressive Disorder or Dysthymic Disorder

NCT00518986 is registered in ClinicalTrials.gov with Cephalon as lead sponsor.

NCT NCT00518986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00518986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome With Major Depressive Disorder or Dysthymic Disorder
Lead sponsor
Cephalon
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2007
Completion date
March 31, 2009
Enrollment
249 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

dysthymic disorder, major depressive disorder, obstructive sleep apnea, sleep disorders